Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Fearon

Showing results (71-80 of 176) with videos related to

Pageof 18
Sort By:
The Journal of Experimental Medicine|February 1, 1974
Properdin factor D: characterization of its active site and isolation of the precursor formD T Fearon, K F Austen, S Ruddy
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1980
Inhibition of the alternative pathway of human complement in vitro by a natural microbial product, complestatinI Kaneko, D T Fearon, K F Austen
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1978
The modulation of the alternative pathway of complement in C2-deficient human serum by changes in concentration of the component and control proteinsU E Nydegger, D T Fearon, K F Austen
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1982
Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronaseF D Moore, K F Austen, D T Fearon
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1981
IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3bF D Moore, D T Fearon, K F Austen
Current Opinion in Immunology|June 1, 1996
Activation of B lymphocytes: integrating signals from CD19, CD22 and Fc gamma RIIb1G M Doody, P W Dempsey, D T Fearon
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1984
Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytesJ J Weis, T F Tedder, D T Fearon
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1983
Characterization of human T lymphocytes that express the C3b receptorJ G Wilson, T F Tedder, D T Fearon
Immunologic Research|January 1, 1987
CR1 and the cell membrane proteins that bind C3 and C4. A basic and clinical reviewJ G Wilson, N A Andriopoulos, D T Fearon
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1976
C3 requirements for formation of alternative pathway C5 convertaseM R Daha, D T Fearon, K F Austen
Pageof 18

Showing results (71-80 of 176) with videos related to

Sort By:
Pageof 18
The Journal of Experimental Medicine|February 1, 1974
Properdin factor D: characterization of its active site and isolation of the precursor formD T Fearon, K F Austen, S Ruddy
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1980
Inhibition of the alternative pathway of human complement in vitro by a natural microbial product, complestatinI Kaneko, D T Fearon, K F Austen
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1978
The modulation of the alternative pathway of complement in C2-deficient human serum by changes in concentration of the component and control proteinsU E Nydegger, D T Fearon, K F Austen
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1982
Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronaseF D Moore, K F Austen, D T Fearon
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1981
IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3bF D Moore, D T Fearon, K F Austen
Current Opinion in Immunology|June 1, 1996
Activation of B lymphocytes: integrating signals from CD19, CD22 and Fc gamma RIIb1G M Doody, P W Dempsey, D T Fearon
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1984
Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytesJ J Weis, T F Tedder, D T Fearon
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1983
Characterization of human T lymphocytes that express the C3b receptorJ G Wilson, T F Tedder, D T Fearon
Immunologic Research|January 1, 1987
CR1 and the cell membrane proteins that bind C3 and C4. A basic and clinical reviewJ G Wilson, N A Andriopoulos, D T Fearon
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1976
C3 requirements for formation of alternative pathway C5 convertaseM R Daha, D T Fearon, K F Austen
Pageof 18